This CDCep™ MSI test Kit employs the gold-standard multiplex fluorescent PCR combined with capillary electrophoresis (PCR-CE) technique to evaluate microsatellite stability in tumor DNA. It targets five microsatellite loci recommended by the U.S. National Cancer Institute (BAT-25, BAT-26, NR-21, NR-24, MONO-27), enabling accurate MSI status determination in solid tumor samples such as colorectal, gastric, and endometrial tissues.Designed for oncology research applications, this kit facilitates in-depth studies related to genomic instability, tumor classification, and biomarker discovery.
Multi-Level Quality Assurance
· Incorporates UDG anti-contamination system, internal QC loci, molecular weight markers, and matched control templates to ensure data reliability.
Automated Data Analysis
· Proprietary software streamlines interpretation with automated peak calling and report generation, enhancing research efficiency.
Accurate Peak Differentiation
· A curated real-world sample database improves resolution of complex stutter patterns in electropherograms.
All-in-One Research Workflow
· An integrated solution combining reagents, instruments, and analysis tools—optimized for seamless laboratory research use.
| Species: | Human |
| Variant Types: | MSI |
| Sample Type: | tumor tissue + adjacent non-tumor tissue |
| Method: | Capillary Electrophoresis(CE) |
| Sequencing Platform: | Applied Biosystems |
MSI Marker:
| NR-24 | NR-27 | BAT-25 | BAT-26 | MONO-27 |
| Penta C | Penta D | Amel |
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×
